Zübeyir Elmazoğlu
-
- Inflammatory mediators and NSAID effects 5
-
- Neuroinflammation and Neurodegeneration Mechanisms 4
-
- Osteoarthritis Treatment and Mechanisms 5
-
- Aldose Reductase and Taurine 4
-
- Biochemical effects in animals 4
-
- Nanoplatforms for cancer theranostics 4
-
- Photodynamic Therapy Research Studies 3
-
- Luminescence and Fluorescent Materials 3
Zübeyir Elmazoğlu
29 papers receiving 371 citations
Peers
Comparison fields: 5 of 76
- Pharmacology 73
- Biological Psychiatry 10
- Biochemistry 22
- Toxicology 12
- Neurology 26
Countries citing papers authored by Zübeyir Elmazoğlu
This map shows the geographic impact of Zübeyir Elmazoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zübeyir Elmazoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zübeyir Elmazoğlu more than expected).
Fields of papers citing papers by Zübeyir Elmazoğlu
This network shows the impact of papers produced by Zübeyir Elmazoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zübeyir Elmazoğlu. The network helps show where Zübeyir Elmazoğlu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zübeyir Elmazoğlu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 12 | |
| 6 | 2021 | 10 | |
| 7 | 2021 | 10 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 5 | |
| 10 | 2020 | 10 | |
| 11 | 2020 | 1 | |
| 12 | 2020 | 11 | |
| 13 | 2020 | 2 | |
| 14 | 2020 | 26 | |
| 15 | 2020 | 5 | |
| 16 | 2019 | 6 | |
| 17 | 2019 | 20 | |
| 18 | 2019 | 11 | |
| 19 | 2018 | 25 | |
| 20 | 2016 | 11 |
About Zübeyir Elmazoğlu
Zübeyir Elmazoğlu is a scholar working on Neurology, Pharmacology and Biochemistry, having authored 30 papers that have together received 373 indexed citations. Recurring topics across this work include Osteoarthritis Treatment and Mechanisms (5 papers), Inflammatory mediators and NSAID effects (5 papers), Aldose Reductase and Taurine (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers), Biochemical effects in animals (4 papers), Nanoplatforms for cancer theranostics (4 papers), Photodynamic Therapy Research Studies (3 papers) and Luminescence and Fluorescent Materials (3 papers). The work is most often cited by research in Pharmacology (73 citations), Biological Psychiatry (10 citations) and Biochemistry (22 citations). Zübeyir Elmazoğlu has collaborated with scholars based in Türkiye, United States and Mexico. Frequent co-authors include Çi̇men Karasu, Ebru Alp, Sevda Menevşe, Abel Santamarı́a, Edgar Rangel‐López, Milan Štefek, Marta Šoltésová Prnová, Isaac Túnez, Görkem Günbaş and Michael Aschner. Their work appears in journals such as Annals of the Rheumatic Diseases, Osteoarthritis and Cartilage and Toxicon.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.